Europe Monoclonal Antibodies Market Report 2016

Europe Monoclonal Antibodies Market Report 2016

1 Monoclonal Antibodies Overview

1.1 Product Overview and Scope of Monoclonal Antibodies

1.2 Classification of Monoclonal Antibodies

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Monoclonal Antibodies

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Monoclonal Antibodies Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Monoclonal Antibodies (2011-2021)

1.5.1 Europe Monoclonal Antibodies Sales and Growth Rate (2011-2021)

1.5.2 Europe Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

2 Europe Monoclonal Antibodies by Manufacturers, Type and Application

2.1 Europe Monoclonal Antibodies Market Competition by Manufacturers

2.1.1 Europe Monoclonal Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Monoclonal Antibodies Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Monoclonal Antibodies (Volume and Value) by Type

2.2.1 Europe Monoclonal Antibodies Sales and Market Share by Type (2011-2016)

2.2.2 Europe Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)

2.3 Europe Monoclonal Antibodies (Volume and Value) by Countries

2.3.1 Europe Monoclonal Antibodies Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Monoclonal Antibodies Revenue and Market Share by Countries (2011-2016)

2.4 Europe Monoclonal Antibodies (Volume) by Application

3 Germany Monoclonal Antibodies (Volume, Value and Sales Price)

3.1 Germany Monoclonal Antibodies Sales and Value (2011-2016)

3.1.1 Germany Monoclonal Antibodies Sales and Growth Rate (2011-2016)

3.1.2 Germany Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

3.1.3 Germany Monoclonal Antibodies Sales Price Trend (2011-2016)

3.2 Germany Monoclonal Antibodies Sales and Market Share by Manufacturers

3.3 Germany Monoclonal Antibodies Sales and Market Share by Type

3.4 Germany Monoclonal Antibodies Sales and Market Share by Application

4 France Monoclonal Antibodies (Volume, Value and Sales Price)

4.1 France Monoclonal Antibodies Sales and Value (2011-2016)

4.1.1 France Monoclonal Antibodies Sales and Growth Rate (2011-2016)

4.1.2 France Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

4.1.4 France Monoclonal Antibodies Sales Price Trend (2011-2016)

4.2 France Monoclonal Antibodies Sales and Market Share by Manufacturers

4.3 France Monoclonal Antibodies Sales and Market Share by Type

4.4 France Monoclonal Antibodies Sales and Market Share by Application

5 UK Monoclonal Antibodies (Volume, Value and Sales Price)

5.1 UK Monoclonal Antibodies Sales and Value (2011-2016)

5.1.1 UK Monoclonal Antibodies Sales and Growth Rate (2011-2016)

5.1.2 UK Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

5.1.5 UK Monoclonal Antibodies Sales Price Trend (2011-2016)

5.2 UK Monoclonal Antibodies Sales and Market Share by Manufacturers

5.3 UK Monoclonal Antibodies Sales and Market Share by Type

5.4 UK Monoclonal Antibodies Sales and Market Share by Application

6 Russia Monoclonal Antibodies (Volume, Value and Sales Price)

6.1 Russia Monoclonal Antibodies Sales and Value (2011-2016)

6.1.1 Russia Monoclonal Antibodies Sales and Growth Rate (2011-2016)

6.1.2 Russia Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

6.1.6 Russia Monoclonal Antibodies Sales Price Trend (2011-2016)

6.2 Russia Monoclonal Antibodies Sales and Market Share by Manufacturers

6.3 Russia Monoclonal Antibodies Sales and Market Share by Type

6.4 Russia Monoclonal Antibodies Sales and Market Share by Application

7 Italy Monoclonal Antibodies (Volume, Value and Sales Price)

7.1 Italy Monoclonal Antibodies Sales and Value (2011-2016)

7.1.1 Italy Monoclonal Antibodies Sales and Growth Rate (2011-2016)

7.1.2 Italy Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

7.1.7 Italy Monoclonal Antibodies Sales Price Trend (2011-2016)

7.2 Italy Monoclonal Antibodies Sales and Market Share by Manufacturers

7.3 Italy Monoclonal Antibodies Sales and Market Share by Type

7.4 Italy Monoclonal Antibodies Sales and Market Share by Application

8 Spain Monoclonal Antibodies (Volume, Value and Sales Price)

8.1 Spain Monoclonal Antibodies Sales and Value (2011-2016)

8.1.1 Spain Monoclonal Antibodies Sales and Growth Rate (2011-2016)

8.1.2 Spain Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

8.1.8 Spain Monoclonal Antibodies Sales Price Trend (2011-2016)

8.2 Spain Monoclonal Antibodies Sales and Market Share by Manufacturers

8.3 Spain Monoclonal Antibodies Sales and Market Share by Type

8.4 Spain Monoclonal Antibodies Sales and Market Share by Application

9 Benelux Monoclonal Antibodies (Volume, Value and Sales Price)

9.1 Benelux Monoclonal Antibodies Sales and Value (2011-2016)

9.1.1 Benelux Monoclonal Antibodies Sales and Growth Rate (2011-2016)

9.1.2 Benelux Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Monoclonal Antibodies Sales Price Trend (2011-2016)

9.2 Benelux Monoclonal Antibodies Sales and Market Share by Manufacturers

9.3 Benelux Monoclonal Antibodies Sales and Market Share by Type

9.4 Benelux Monoclonal Antibodies Sales and Market Share by Application

10 Europe Monoclonal Antibodies Manufacturers Analysis

10.1 AbbVie

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Monoclonal Antibodies Product Type, Application and Specification

10.1.2.1 Type I

10.1.2.2 Type II

10.1.3 AbbVie Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Amgen

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Monoclonal Antibodies Product Type, Application and Specification

10.2.2.1 Type I

10.2.2.2 Type II

10.2.3 Amgen Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Bristol-Myers Squibb

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Monoclonal Antibodies Product Type, Application and Specification

10.3.2.1 Type I

10.3.2.2 Type II

10.3.3 Bristol-Myers Squibb Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 F. Hoffmann-La Roche

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Monoclonal Antibodies Product Type, Application and Specification

10.4.2.1 Type I

10.4.2.2 Type II

10.4.3 F. Hoffmann-La Roche Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Johnson & Johnson

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Monoclonal Antibodies Product Type, Application and Specification

10.5.2.1 Type I

10.5.2.2 Type II

10.5.3 Johnson & Johnson Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Merck

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Monoclonal Antibodies Product Type, Application and Specification

10.6.2.1 Type I

10.6.2.2 Type II

10.6.3 Merck Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 AbGenomics

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Monoclonal Antibodies Product Type, Application and Specification

10.7.2.1 Type I

10.7.2.2 Type II

10.7.3 AbGenomics Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 ADC Therapeutics, Agensys

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Monoclonal Antibodies Product Type, Application and Specification

10.8.2.1 Type I

10.8.2.2 Type II

10.8.3 ADC Therapeutics, Agensys Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Alexion Pharmaceuticals

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Monoclonal Antibodies Product Type, Application and Specification

10.9.2.1 Type I

10.9.2.2 Type II

10.9.3 Alexion Pharmaceuticals Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 ALMAC Group

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Monoclonal Antibodies Product Type, Application and Specification

10.10.2.1 Type I

10.10.2.2 Type II

10.10.3 ALMAC Group Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

11 Monoclonal Antibodies Manufacturing Cost Analysis

11.1 Monoclonal Antibodies Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Monoclonal Antibodies

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Monoclonal Antibodies Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Monoclonal Antibodies Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Monoclonal Antibodies Market Forecast (2016-2021)

14.1 Germany Monoclonal Antibodies Sales Forecast (2016-2021)

14.2 France Monoclonal Antibodies Sales Forecast (2016-2021)

14.3 UK Monoclonal Antibodies Sales Forecast (2016-2021)

14.4 Russia Monoclonal Antibodies Sales Forecast (2016-2021)

14.5 Italy Monoclonal Antibodies Sales Forecast (2016-2021)

14.6 Spain Monoclonal Antibodies Sales Forecast (2016-2021)

14.7 Benelux Monoclonal Antibodies Sales Forecast (2016-2021)

14.8 Europe Monoclonal Antibodies Sales Forecast by Type (2016-2021)

14.9 Europe Monoclonal Antibodies Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Monoclonal Antibodies

Table Classification of Monoclonal Antibodies

Figure Europe Sales Market Share of Monoclonal Antibodies by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Application of Monoclonal Antibodies

Figure Europe Sales Market Share of Monoclonal Antibodies by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Germany Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

Figure France Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

Figure UK Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

Figure Russia Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

Figure Italy Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

Figure Spain Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

Figure Benelux Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

Figure Europe Monoclonal Antibodies Sales and Growth Rate (2011-2021)

Figure Europe Monoclonal Antibodies Revenue and Growth Rate (2011-2021)

Table Europe Monoclonal Antibodies Sales of Key Manufacturers (2015 and 2016)

Table Europe Monoclonal Antibodies Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Monoclonal Antibodies Sales Share by Manufacturers

Figure 2016 Monoclonal Antibodies Sales Share by Manufacturers

Table Europe Monoclonal Antibodies Revenue by Manufacturers (2015 and 2016)

Table Europe Monoclonal Antibodies Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Monoclonal Antibodies Revenue Share by Manufacturers

Table 2016 Europe Monoclonal Antibodies Revenue Share by Manufacturers

Table Europe Monoclonal Antibodies Sales and Market Share by Type (2011-2016)

Table Europe Monoclonal Antibodies Sales Share by Type (2011-2016)

Figure Sales Market Share of Monoclonal Antibodies by Type (2011-2016)

Figure Europe Monoclonal Antibodies Sales Growth Rate by Type (2011-2016)

Table Europe Monoclonal Antibodies Revenue and Market Share by Type (2011-2016)

Table Europe Monoclonal Antibodies Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Monoclonal Antibodies by Type (2011-2016)

Figure Europe Monoclonal Antibodies Revenue Growth Rate by Type (2011-2016)

Table Europe Monoclonal Antibodies Sales and Market Share by Countries (2011-2016)

Table Europe Monoclonal Antibodies Sales Share by Countries (2011-2016)

Figure Sales Market Share of Monoclonal Antibodies by Countries (2011-2016)

Table Europe Monoclonal Antibodies Revenue and Market Share by Countries (2011-2016)

Table Europe Monoclonal Antibodies Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Monoclonal Antibodies by Countries (2011-2016)

Table Europe Monoclonal Antibodies Sales and Market Share by Application (2011-2016)

Table Europe Monoclonal Antibodies Sales Share by Application (2011-2016)

Figure Sales Market Share of Monoclonal Antibodies by Application (2011-2016)

Figure Germany Monoclonal Antibodies Sales and Growth Rate (2011-2016)

Figure Germany Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

Figure Germany Monoclonal Antibodies Sales Price Trend (2011-2016)

Table Germany Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)

Table Germany Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)

Table Germany Monoclonal Antibodies Sales by Type (2015 and 2016)

Table Germany Monoclonal Antibodies Market Share by Type (2015 and 2016)

Table Germany Monoclonal Antibodies Sales by Application (2015 and 2016)

Table Germany Monoclonal Antibodies Market Share by Application (2015 and 2016)

Figure France Monoclonal Antibodies Sales and Growth Rate (2011-2016)

Figure France Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

Figure France Monoclonal Antibodies Sales Price Trend (2011-2016)

Table France Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)

Table France Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)

Table France Monoclonal Antibodies Sales by Type (2015 and 2016)

Table France Monoclonal Antibodies Market Share by Type (2015 and 2016)

Table France Monoclonal Antibodies Sales by Application (2015 and 2016)

Table France Monoclonal Antibodies Market Share by Application (2015 and 2016)

Figure UK Monoclonal Antibodies Sales and Growth Rate (2011-2016)

Figure UK Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

Figure UK Monoclonal Antibodies Sales Price Trend (2011-2016)

Table UK Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)

Table UK Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)

Table UK Monoclonal Antibodies Sales by Type (2015 and 2016)

Table UK Monoclonal Antibodies Market Share by Type (2015 and 2016)

Table UK Monoclonal Antibodies Sales by Application (2015 and 2016)

Table UK Monoclonal Antibodies Market Share by Application (2015 and 2016)

Figure Russia Monoclonal Antibodies Sales and Growth Rate (2011-2016)

Figure Russia Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

Figure Russia Monoclonal Antibodies Sales Price Trend (2011-2016)

Table Russia Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)

Table Russia Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)

Table Russia Monoclonal Antibodies Sales by Type (2015 and 2016)

Table Russia Monoclonal Antibodies Market Share by Type (2015 and 2016)

Table Russia Monoclonal Antibodies Sales by Application (2015 and 2016)

Table Russia Monoclonal Antibodies Market Share by Application (2015 and 2016)

Figure Italy Monoclonal Antibodies Sales and Growth Rate (2011-2016)

Figure Italy Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

Figure Italy Monoclonal Antibodies Sales Price Trend (2011-2016)

Table Italy Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)

Table Italy Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)

Table Italy Monoclonal Antibodies Sales by Type (2015 and 2016)

Table Italy Monoclonal Antibodies Market Share by Type (2015 and 2016)

Table Italy Monoclonal Antibodies Sales by Application (2015 and 2016)

Table Italy Monoclonal Antibodies Market Share by Application (2015 and 2016)

Figure Spain Monoclonal Antibodies Sales and Growth Rate (2011-2016)

Figure Spain Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

Figure Spain Monoclonal Antibodies Sales Price Trend (2011-2016)

Table Spain Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)

Table Spain Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)

Table Spain Monoclonal Antibodies Sales by Type (2015 and 2016)

Table Spain Monoclonal Antibodies Market Share by Type (2015 and 2016)

Table Spain Monoclonal Antibodies Sales by Application (2015 and 2016)

Table Spain Monoclonal Antibodies Market Share by Application (2015 and 2016)

Figure Benelux Monoclonal Antibodies Sales and Growth Rate (2011-2016)

Figure Benelux Monoclonal Antibodies Revenue and Growth Rate (2011-2016)

Figure Benelux Monoclonal Antibodies Sales Price Trend (2011-2016)

Table Benelux Monoclonal Antibodies Sales by Manufacturers (2015 and 2016)

Table Benelux Monoclonal Antibodies Market Share by Manufacturers (2015 and 2016)

Table Benelux Monoclonal Antibodies Sales by Type (2015 and 2016)

Table Benelux Monoclonal Antibodies Market Share by Type (2015 and 2016)

Table Benelux Monoclonal Antibodies Sales by Application (2015 and 2016)

Table Benelux Monoclonal Antibodies Market Share by Application (2015 and 2016)

Table Monoclonal Antibodies Basic Information List

Table AbbVie Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Figure AbbVie Monoclonal Antibodies Sales Market Share (2011-2016)

Table Amgen Basic Information List

Table Amgen Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table Amgen Monoclonal Antibodies Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Monoclonal Antibodies Sales Market Share (2011-2016)

Table F. Hoffmann-La Roche Basic Information List

Table F. Hoffmann-La Roche Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table F. Hoffmann-La Roche Monoclonal Antibodies Sales Market Share (2011-2016)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table Johnson & Johnson Monoclonal Antibodies Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Monoclonal Antibodies Sales Market Share (2011-2016)

Table AbGenomics Basic Information List

Table AbGenomics Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table AbGenomics Monoclonal Antibodies Sales Market Share (2011-2016)

Table ADC Therapeutics, Agensys Basic Information List

Table ADC Therapeutics, Agensys Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table ADC Therapeutics, Agensys Monoclonal Antibodies Sales Market Share (2011-2016)

Table Alexion Pharmaceuticals Basic Information List

Table Alexion Pharmaceuticals Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table Alexion Pharmaceuticals Monoclonal Antibodies Sales Market Share (2011-2016)

Table ALMAC Group Basic Information List

Table ALMAC Group Monoclonal Antibodies Sales, Revenue, Price and Gross Margin (2011-2016)

Table ALMAC Group Monoclonal Antibodies Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Monoclonal Antibodies

Figure Manufacturing Process Analysis of Monoclonal Antibodies

Figure Monoclonal Antibodies Industrial Chain Analysis

Table Raw Materials Sources of Monoclonal Antibodies Major Manufacturers in 2015

Table Major Buyers of Monoclonal Antibodies

Table Distributors/Traders List

Figure Germany Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)

Figure Germany Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)

Figure France Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)

Figure France Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)

Figure UK Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)

Figure UK Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)

Figure Russia Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)

Figure Italy Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)

Figure Spain Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Monoclonal Antibodies Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Monoclonal Antibodies Revenue and Growth Rate Forecast (2016-2021)

Table Europe Monoclonal Antibodies Sales Forecast by Type (2016-2021)

Table Europe Monoclonal Antibodies Sales Forecast by Application (2016-2021)